Cargando…
Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis?
CONTEXT: Previous studies demonstrated faster correction of metabolic derangement associated with hypertrophic pyloric stenosis with pre-operative intravenous (IV) histamine-2 receptor antagonists. AIMS: We investigated if similar outcomes are achieved with IV pantoprazole, a proton-pump inhibitor (...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759415/ https://www.ncbi.nlm.nih.gov/pubmed/34916353 http://dx.doi.org/10.4103/ajps.AJPS_9_21 |
_version_ | 1784633103668477952 |
---|---|
author | Fourie, Natasha Arnold, Marion Banieghbal, Behrouz Marchant, Samantha Lynn |
author_facet | Fourie, Natasha Arnold, Marion Banieghbal, Behrouz Marchant, Samantha Lynn |
author_sort | Fourie, Natasha |
collection | PubMed |
description | CONTEXT: Previous studies demonstrated faster correction of metabolic derangement associated with hypertrophic pyloric stenosis with pre-operative intravenous (IV) histamine-2 receptor antagonists. AIMS: We investigated if similar outcomes are achieved with IV pantoprazole, a proton-pump inhibitor (PPI), including the subgroup of delayed presenters in the South African setting. SETTINGS AND DESIGN: A 5-year retrospective record review (January 2014–December 2018) compared the rate of metabolic correction in patients with hypertrophic pyloric stenosis at two tertiary centres. SUBJECTS AND METHODS: One centre routinely administers IV pantoprazole (1 mg/kg daily) preoperatively (PPI group) and the other does not (non-PPI group). Fluid administration, chloride supplementation and post-operative emesis were evaluated. STATISTICAL ANALYSIS: Spearman's rank correlation coefficient was used to calculate statistical significance for discrete dependent variables. Continuous variables were compared between the groups using the Student t-test. Fisher's exact contingency tables were used to classify categorical data and to assess the significance of outcome between two treatment options. P < 0.05 was considered statistically significant. RESULTS: Forty-two patients received IV pantoprazole and 24 did not. The mean time of metabolic correction was 8 h shorter in the PPI group (P = 0.067). Total pre-operative chloride administration correlated to the rate of metabolic correction in both cohorts (P < 0.0001). Profound hypochloraemia (chloride <85 mmol/l) was corrected 23 h faster in the PPI group (P < 0.004). Post-operative emesis was noted: 0.45 episodes/patient in the PPI group and 0.75 episodes/patient in the non-PPI group (P = 0.01). CONCLUSIONS: Pre-operative IV pantoprazole administration showed a faster correction of metabolic derangements, and in profound hypochloraemia, the correction occurred substantially faster in the PPI group. Post-operative emesis was significantly less frequent in the PPI group. |
format | Online Article Text |
id | pubmed-8759415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-87594152022-01-21 Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis? Fourie, Natasha Arnold, Marion Banieghbal, Behrouz Marchant, Samantha Lynn Afr J Paediatr Surg Original Article CONTEXT: Previous studies demonstrated faster correction of metabolic derangement associated with hypertrophic pyloric stenosis with pre-operative intravenous (IV) histamine-2 receptor antagonists. AIMS: We investigated if similar outcomes are achieved with IV pantoprazole, a proton-pump inhibitor (PPI), including the subgroup of delayed presenters in the South African setting. SETTINGS AND DESIGN: A 5-year retrospective record review (January 2014–December 2018) compared the rate of metabolic correction in patients with hypertrophic pyloric stenosis at two tertiary centres. SUBJECTS AND METHODS: One centre routinely administers IV pantoprazole (1 mg/kg daily) preoperatively (PPI group) and the other does not (non-PPI group). Fluid administration, chloride supplementation and post-operative emesis were evaluated. STATISTICAL ANALYSIS: Spearman's rank correlation coefficient was used to calculate statistical significance for discrete dependent variables. Continuous variables were compared between the groups using the Student t-test. Fisher's exact contingency tables were used to classify categorical data and to assess the significance of outcome between two treatment options. P < 0.05 was considered statistically significant. RESULTS: Forty-two patients received IV pantoprazole and 24 did not. The mean time of metabolic correction was 8 h shorter in the PPI group (P = 0.067). Total pre-operative chloride administration correlated to the rate of metabolic correction in both cohorts (P < 0.0001). Profound hypochloraemia (chloride <85 mmol/l) was corrected 23 h faster in the PPI group (P < 0.004). Post-operative emesis was noted: 0.45 episodes/patient in the PPI group and 0.75 episodes/patient in the non-PPI group (P = 0.01). CONCLUSIONS: Pre-operative IV pantoprazole administration showed a faster correction of metabolic derangements, and in profound hypochloraemia, the correction occurred substantially faster in the PPI group. Post-operative emesis was significantly less frequent in the PPI group. Wolters Kluwer - Medknow 2022 2021-12-14 /pmc/articles/PMC8759415/ /pubmed/34916353 http://dx.doi.org/10.4103/ajps.AJPS_9_21 Text en Copyright: © 2022 African Journal of Paediatric Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Fourie, Natasha Arnold, Marion Banieghbal, Behrouz Marchant, Samantha Lynn Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis? |
title | Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis? |
title_full | Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis? |
title_fullStr | Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis? |
title_full_unstemmed | Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis? |
title_short | Is there any Benefit with Pantoprazole Treatment in Infantile Hypertrophic Pyloric Stenosis? |
title_sort | is there any benefit with pantoprazole treatment in infantile hypertrophic pyloric stenosis? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759415/ https://www.ncbi.nlm.nih.gov/pubmed/34916353 http://dx.doi.org/10.4103/ajps.AJPS_9_21 |
work_keys_str_mv | AT fourienatasha isthereanybenefitwithpantoprazoletreatmentininfantilehypertrophicpyloricstenosis AT arnoldmarion isthereanybenefitwithpantoprazoletreatmentininfantilehypertrophicpyloricstenosis AT banieghbalbehrouz isthereanybenefitwithpantoprazoletreatmentininfantilehypertrophicpyloricstenosis AT marchantsamanthalynn isthereanybenefitwithpantoprazoletreatmentininfantilehypertrophicpyloricstenosis |